Senior Director, Global Pharmacovigilance Quality Assurance Lead

Alnylam Pharmaceuticals, Inc.

Philadelphia (Philadelphia County)

Hybrid

USD 228,000 - 308,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals is seeking a Senior Director, Global Pharmacovigilance Quality Assurance Lead to provide executive leadership and independent oversight of the global PV quality system. This role guides strategy, governance, and risk-based assurance to support compliance and growth.

Hybrid work options include Cambridge, MA or Philadelphia, PA or remote within the United States. The role partners with Safety, Quality, Regulatory, and Clinical teams to enable compliant execution and

Qualifications

  • Broad knowledge of international GVP regulations and guidance; FDA/EMA/Health Canada familiarity.
  • Proven ability to design and scale an independent PV QA function in a matrix environment.
  • Experience with risk-based audits and health-authority inspections, including QPPV/PSMF context.
  • Executive presence enabling alignment of stakeholders while preserving decision rights.

Responsibilities

  • Provide strategic leadership for global PV QA function and governance.
  • Oversee quality events, CAPAs, and remediation to ensure regulatory compliance.
  • Own risk-based PV audit strategy and partner with enterprise audit operations.
  • Lead inspection readiness and represent PV QA during global health authority inspections.
  • Ensure validation, data integrity, and change control for PV computerized systems.

Skills

PV QA leadership
Regulatory compliance
GVP audits
Executive communication

Education

Bachelor's degree in a scientific field
Advanced degree preferred

Job description

Overview:

The Senior Director, Global Pharmacovigilance Quality Assurance Lead provides executive leadership and independent quality oversight of Alnylam's global pharmacovigilance quality system. Reporting to the Vice President, R&D Quality, the role sets the strategic direction for the GVP QA function and provides independent assurance and escalation regarding the effectiveness of PV procedures, systems, and governance. As Alnylam continues to expand its global portfolio and organizational complexity, the Senior Director will lead the continued evolution of the PV Quality Assurance function, strengthening independent oversight, governance, risk-based assurance, quality-system performance monitoring, and inspection-readiness capabilities to support sustainable growth, operational excellence, and long-term regulatory compliance.

This role can be based in Cambridge, MA or Philadelphia, PA in a hybrid work arrangement, or remotely within the United States.

Key Responsibilities:
  • Provides strategic leadership for Alnylam's global Pharmacovigilance (PV) Quality Assurance function, including long-term strategy, operating model, organizational design, talent development, and quality culture grounded in integrity, transparency, and continuous improvement.
  • Leads and evolves the PV QA governance framework, overseeing compliance risk management, quality metrics, trend analysis, management reviews, and escalation of significant quality and regulatory risks.
  • Serves as the independent QA authority for the pharmacovigilance quality system, providing oversight of quality events, CAPAs, compliance assessments, and remediation activities to ensure regulatory compliance and effectiveness.
  • Owns the risk-based GVP audit strategy and PV assurance program. Partners with enterprise audit operations to conduct robust, risk-based audits of internal processes, vendors, and delegated partners while driving continuous improvement and risk mitigation across the PV ecosystem.
  • Provides independent assurance over computerized systems supporting pharmacovigilance, including validation, data integrity, and change control, and oversees GVP QA contributions to the Pharmacovigilance System Master File (PSMF).
  • Leads PV Quality Assurance inspection readiness in partnership with key enterprise stakeholders. Serves as a key representative during global health authority inspections, ensuring effective preparation, response management, and remediation oversight, including independent review of responses and remediation actions.
  • Partners broadly across Safety, Quality, Regulatory, Clinical, Commercial, and enterprise functions to enable compliant execution, strengthen governance, align quality processes, and maintain independent QA decision rights and escalation authority.
Qualifications:
  • Bachelor's degree in a scientific, healthcare, or related discipline; advanced degree such as MSc, PharmD, or PhD preferred.
  • 12-15+ years of experience in pharmacovigilance quality assurance, regulated pharmacovigilance, or a related quality/compliance function, including substantial leadership experience.
  • Thorough knowledge of international GVP regulations and guidance, including FDA requirements, EMA GVP Modules, Health Canada requirements, and applicable ICH guidance; working knowledge of GCP interfaces is expected.
  • Demonstrated success strengthening, scaling, or transforming an independent PV Quality Assurance function, operating model, governance framework, risk-based assurance program, audit strategy, quality metrics, and continuous-improvement capabilities in a matrixed environment.
  • Proven experience with risk-based GVP audits and health-authority inspections, including QPPV and PSMF-related scope.
  • Executive presence and demonstrated ability to align operational, embedded compliance, and independent Quality Assurance stakeholders while preserving clear decision rights and escalation authority.
  • Excellent problem-solving, decision-making, negotiation, communication, and conflict-resolution skills.
About Alnylam

We are the leader in RNAi therapeutics- a revolutionaryapproach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possibleand are just at the beginning of what's possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, wherean authentic, inclusive culture and breakthrough thinkingfuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Before applying, please review Alnylam's CandidatePrivacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website:https://www.alnylam.com/careers

U.S. Pay Range

$227,900—$308,300 USD

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Director, Global Pharmacovigilance Quality Assurance Lead
Senior Director, Global Pharmacovigilance Quality Assurance Lead

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 228,000 - 308,000
Senior Director, Global Pharmacovigilance Quality Assurance Lead
Senior Director, Global Pharmacovigilance Quality Assurance Lead

Alnylam • Cambridge (MA)

Hybrid
USD 230,000 - 320,000
Vice President, Head of Pharmacovigilance Operations, Innovation & Analytics
Vice President, Head of Pharmacovigilance Operations, Innovation & Analytics

Regulatory Toolkit • Cambridge (MA)

Hybrid
USD 289,000 - 391,000
Director, Pharmacovigilance & Safety Technology
Director, Pharmacovigilance & Safety Technology

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 180,000 - 260,000
Senior Director, Global Environmental Health, Safety and Sustainability
Senior Director, Global Environmental Health, Safety and Sustainability

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

On-site
USD 216,000 - 293,000
Medical insurance
Dental insurance
Vision coverage
+2
Director, Medical Safety and Risk Management
Director, Medical Safety and Risk Management

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

On-site
USD 180,000 - 250,000
Associate Director, Regulatory Affairs
Associate Director, Regulatory Affairs

Alnylam • Philadelphia

Hybrid
USD 171,000 - 231,000
Senior Manager, R&D Quality Assurance
Senior Manager, R&D Quality Assurance

Regulatory Toolkit • Cambridge (MA)

Hybrid
USD 130,000 - 190,000
Senior Manager, R&D Quality Assurance
Senior Manager, R&D Quality Assurance

Alnylam Pharmaceuticals, Inc. • Cambridge (MA), Philadelphia

Hybrid
USD 140,000 - 200,000
Hybrid work model
Director, Regulatory Technology
Director, Regulatory Technology

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

On-site
USD 187,000 - 254,000
Medical benefits
401(k) matching
Paid time off